Inhibrx Biosciences, Inc.
Non-immunogenic single domain antibodies
Last updated:
Abstract:
The invention provides modifications within human or humanized single domain antibody fragments (sdAbs) that prevent recognition by pre-existing antibodies, to isolated polypeptides that include these modifications, and to methods and uses thereof.
Status:
Grant
Type:
Utility
Filling date:
21 Jan 2016
Issue date:
7 Jan 2020